May 4, 2012

By Ellin Holohan
HealthDay Reporter
FRIDAY, May 4 (HealthDay News) — A new study suggests that severe weight gain might raise the risk for rheumatoid arthritis — a painful, chronic ailment — especially among obese women.
The epidemiological research indicated that about half of the increase in rheumatoid arthritis cases in one Minnesota county may be linked to rising obesity rates there over three decades.
Read More
April 5, 2012

THURSDAY, April 5 (HealthDay News) — More aggressive treatment for people in the early stages of rheumatoid arthritis (RA) is among the most important changes recommended in updated American College of Rheumatology treatment guidelines.
This change is the result of emerging opinions that RA-related joint damage is irreversible and that early, intensive treatment helps preserve patients’ physical function, quality of life and ability to work.
Read More
March 28, 2012

By Steven Reinberg
HealthDay Reporter
WEDNESDAY, March 28 (HealthDay News) — People suffering from rheumatoid arthritis who stop taking their cholesterol-lowering drugs may raise their risk of dying, a new study finds.
In fact, those who stopped taking statins raised their chances of dying from cardiovascular disease by 60 percent and dying from any cause by 79 percent during the course of the study, the Canadian researchers reported.
Read More
February 16, 2012

THURSDAY, Feb. 16 (HealthDay News) — Women with rheumatoid arthritis or systemic lupus erythematosus often have fewer children than they’d hoped for, according to a new study.
These autoimmune diseases, which typically develop during women’s reproductive years, cause fertility problems and miscarriage, researchers said.
Read More
January 26, 2012

By Steven Reinberg
HealthDay Reporter
THURSDAY, Jan. 26 (HealthDay News) — More than 40 percent of rheumatoid arthritis patients live a sedentary life, a new study finds.
It used to be thought that medication and rest was the best treatment, but now experts believe physical activity is important to keep joints flexible, improve balance and strength and reduce pain, the researchers noted.
Read More
December 21, 2011

WEDNESDAY, Dec. 21 (HealthDay News) — Starting aquatic therapy within days after total knee replacement appears to improve patient outcomes, but that’s not the case for those who’ve had a total hip replacement, according to a new study.
The number of patients having total knee and hip replacements is increasing, but there is a lack of agreement about the best type of post-surgical treatment, noted the German researchers.
Read More
December 20, 2011

By Randy Dotinga
HealthDay Reporter
TUESDAY, Dec. 20 (HealthDay News) — A small study finds that mindfulness training, which teaches people to push away troublesome thoughts, helped improve well-being in people with rheumatoid arthritis and similar diseases.
Patients in Norway who received the training didn’t have less pain compared to those who didn’t receive the training, but researchers found they coped better, were less tired and showed less stress.
Read More
November 25, 2011

FRIDAY, Nov. 25 (HealthDay News) — Patients hospitalized for autoimmune disorders, like rheumatoid arthritis or Crohn’s disease, may be at greater risk for a life-threatening pulmonary embolism, a clot in a main artery of the lung, a new study finds.
Reporting online Nov. 25 in The Lancet, researchers warned that steps should be taken to prevent this condition among patients admitted to the hospital for autoimmune diseases.
Read More
November 17, 2011

THURSDAY, Nov. 17 (HealthDay News) — Inflammation caused by psoriasis may trigger changes in a person’s cholesterol, including weakening the function of high-density lipoprotein (HDL), the “good” cholesterol, new research suggests.
The researchers said that, if confirmed, their findings could help explain why people with psoriasis — a chronic skin condition — are at greater risk for heart attack, stroke and cardiovascular death, especially if the psoriasis is moderate to severe.
Read More
November 7, 2011
Getty Images
By Amanda Gardner
MONDAY, November 7, 2011 (Health.com) — A class of injectable drugs used to treat autoimmune disorders such as rheumatoid arthritis doesn’t raise the risk of serious infection when compared with more conventional treatments, according to a new analysis in the Journal of the American Medical Association.
The research, which was funded by the Food and Drug Administration and other federal health agencies, contradicts numerous earlier studies that did find an increased risk of infection associated with the drugs, known as tumor necrosis factor (TNF) inhibitors. Read More